RDIF and Minapharm agree to produce over 40 million doses of the Sputnik V vaccine in Egypt

The Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund), Egypt’s Minapharm, the regional leader in recombinant DNA technology, and its Berlin-based subsidiary, ProBioGen AG, announce the agreement to produce

Read More

1 2 3 142